Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan-Henrik Mikesch

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Blood|January 17, 2017
Folding two lobes, you don't get a cup?Jan-Henrik Mikesch, Christoph Schliemann
Cancer Treatment Reviews|May 23, 2022
Emerging antibody-based therapies for the treatment of acute myeloid leukemiaLinus Angenendt, Jan-Henrik Mikesch, Christoph Schliemann
Cancer Cell|February 18, 2010
Discovery of novel transcriptional and epigenetic targets in APL by global ChIP analyses: Emerging opportunity and challengeJan-Henrik Mikesch, Hinrich Gronemeyer, Chi Wai Eric So
Biochimica Et Biophysica Acta|June 21, 2006
Decay-accelerating factor (CD55): a versatile acting molecule in human malignanciesJan-Henrik Mikesch, Horst Buerger, Ronald Simon, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|December 15, 2006
The expression and action of decay-accelerating factor (CD55) in human malignancies and cancer therapyJan-Henrik Mikesch, Kathrin Schier, Antje Roetger, et al.
Annals of Hematology|June 19, 2007
Diffuse pneumatosis due to central venous catheterization in a patient with acute graft-versus-host diseaseJan-Henrik Mikesch, Andreas Burchert, Oliver Kress, et al.
Cancers|July 2, 2021
Pulmonary Toxicity after Total Body Irradiation-An Underrated Complication? Estimation of Risk via Normal Tissue Complication Probability Calculations and Correlation with Clinical DataMichael Oertel, Christopher Kittel, Jonas Martel, et al.
Leukemia & Lymphoma|June 2, 2025
Prognostic impact of WBC kinetics after induction therapy in patients with acute myeloid leukemia (AML)Jesamine Jany, Jan-Henrik Mikesch, Klaus Wethmar, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
RNA-Guided CRISPR-Cas9 System-Mediated Engineering of Acute Myeloid Leukemia MutationsOliver Brabetz, Vijay Alla, Linus Angenendt, et al.
Annals of Hematology|December 20, 2020
Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaLinus Angenendt, Isabel Hilgefort, Jan-Henrik Mikesch, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Blood|January 17, 2017
Folding two lobes, you don't get a cup?Jan-Henrik Mikesch, Christoph Schliemann
Cancer Treatment Reviews|May 23, 2022
Emerging antibody-based therapies for the treatment of acute myeloid leukemiaLinus Angenendt, Jan-Henrik Mikesch, Christoph Schliemann
Cancer Cell|February 18, 2010
Discovery of novel transcriptional and epigenetic targets in APL by global ChIP analyses: Emerging opportunity and challengeJan-Henrik Mikesch, Hinrich Gronemeyer, Chi Wai Eric So
Biochimica Et Biophysica Acta|June 21, 2006
Decay-accelerating factor (CD55): a versatile acting molecule in human malignanciesJan-Henrik Mikesch, Horst Buerger, Ronald Simon, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|December 15, 2006
The expression and action of decay-accelerating factor (CD55) in human malignancies and cancer therapyJan-Henrik Mikesch, Kathrin Schier, Antje Roetger, et al.
Annals of Hematology|June 19, 2007
Diffuse pneumatosis due to central venous catheterization in a patient with acute graft-versus-host diseaseJan-Henrik Mikesch, Andreas Burchert, Oliver Kress, et al.
Cancers|July 2, 2021
Pulmonary Toxicity after Total Body Irradiation-An Underrated Complication? Estimation of Risk via Normal Tissue Complication Probability Calculations and Correlation with Clinical DataMichael Oertel, Christopher Kittel, Jonas Martel, et al.
Leukemia & Lymphoma|June 2, 2025
Prognostic impact of WBC kinetics after induction therapy in patients with acute myeloid leukemia (AML)Jesamine Jany, Jan-Henrik Mikesch, Klaus Wethmar, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
RNA-Guided CRISPR-Cas9 System-Mediated Engineering of Acute Myeloid Leukemia MutationsOliver Brabetz, Vijay Alla, Linus Angenendt, et al.
Annals of Hematology|December 20, 2020
Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaLinus Angenendt, Isabel Hilgefort, Jan-Henrik Mikesch, et al.
Pageof 9